Frontiers in Neuroscience (Oct 2023)

Exploring the brain epitranscriptome: perspectives from the NSAS summit

  • Sung-Min Lee,
  • Sung-Min Lee,
  • Bonsang Koo,
  • Bonsang Koo,
  • Clément Carré,
  • André Fischer,
  • Chuan He,
  • Chuan He,
  • Ajeet Kumar,
  • Ajeet Kumar,
  • Kathy Liu,
  • Kate D. Meyer,
  • Kate D. Meyer,
  • Guo-li Ming,
  • Guo-li Ming,
  • Guo-li Ming,
  • Guo-li Ming,
  • Junmin Peng,
  • Junmin Peng,
  • Jean-Yves Roignant,
  • Jean-Yves Roignant,
  • Erik Storkebaum,
  • Shuying Sun,
  • Davide De Pietri Tonelli,
  • Yinsheng Wang,
  • Yi-Lan Weng,
  • Luigi Pulvirenti,
  • Yanhong Shi,
  • Ki-Jun Yoon,
  • Ki-Jun Yoon,
  • Hongjun Song,
  • Hongjun Song,
  • Hongjun Song,
  • Hongjun Song

DOI
https://doi.org/10.3389/fnins.2023.1291446
Journal volume & issue
Vol. 17

Abstract

Read online

Increasing evidence reinforces the essential function of RNA modifications in development and diseases, especially in the nervous system. RNA modifications impact various processes in the brain, including neurodevelopment, neurogenesis, neuroplasticity, learning and memory, neural regeneration, neurodegeneration, and brain tumorigenesis, leading to the emergence of a new field termed neuroepitranscriptomics. Deficiency in machineries modulating RNA modifications has been implicated in a range of brain disorders from microcephaly, intellectual disability, seizures, and psychiatric disorders to brain cancers such as glioblastoma. The inaugural NSAS Challenge Workshop on Brain Epitranscriptomics hosted in Crans-Montana, Switzerland in 2023 assembled a group of experts from the field, to discuss the current state of the field and provide novel translational perspectives. A summary of the discussions at the workshop is presented here to simulate broader engagement from the general neuroscience field.

Keywords